SDS

Acute inhalation toxicity
LC50 (male/female combined rat) > 5.125 mg/l
Exposure time: 4 h
Determined in the form of a respirable aerosol.
(actual)
LC50 (male/female combined rat) > 20.5 mg/l
Exposure time: 1 h
Determined in the form of a respirable aerosol.
Extrapolated from the 4 hr LC50.
(actual)
Acute dermal toxicity
LD50 (male/female combined rat) > 4,000 mg/kg
Skin irritation
Slight irritation (rabbit)
Eye irritation
Slight irritation (rabbit)
Sensitisation
Non-sensitizing. (guinea pig)
Assessment repeated dose toxicity
Tau-fluvalinate did not cause specific target organ toxicity in experimental animal studies.
Tebuconazole did not cause specific target organ toxicity in experimental animal studies.
Assessment Mutagenicity
Tau-fluvalinate was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.
Tebuconazole was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.
Assessment Carcinogenicity
Tau-fluvalinate was not carcinogenic in lifetime feeding studies in rats and mice.
Tebuconazole caused at high dose levels an increased incidence of tumours in mice in the following
organ(s): liver. The mechanism of tumour formation is not considered to be relevant to man.
ACGIH
None.
NTP
None.
IARC
None.
OSHA
None.
Assessment toxicity to reproduction
Tau-fluvalinate did not cause reproductive toxicity in a two-generation study in rats.
Tebuconazole caused reproduction toxicity in a two-generation study in rats only at dose levels also
toxic to the parent animals. The reproduction toxicity seen with Tebuconazole is related to parental
toxicity.
Assessment developmental toxicity
SBM LIFE SCIENCE CORP.
SAFETY DATA SHEET
BIOADVANCED SCIENCE-BASED
SOLUTIONS ALL-IN-ONE ROSE & FLOWER
SPRAY CONCENTRATE
Version 1.0 /
USA
102000030487
7/10
Revision Date: 05/01/2017